nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ACE—chronic obstructive pulmonary disease	0.229	0.472	CbGaD
Losartan—CYP1A2—chronic obstructive pulmonary disease	0.162	0.335	CbGaD
Losartan—ALB—chronic obstructive pulmonary disease	0.0937	0.193	CbGaD
Losartan—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0287	0.0999	CbGbCtD
Losartan—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0287	0.0999	CbGbCtD
Losartan—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0259	0.0902	CbGbCtD
Losartan—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0239	0.083	CbGbCtD
Losartan—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0239	0.083	CbGbCtD
Losartan—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0225	0.0784	CbGbCtD
Losartan—ALB—Prednisone—chronic obstructive pulmonary disease	0.0186	0.0647	CbGbCtD
Losartan—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0183	0.0637	CbGbCtD
Losartan—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0181	0.0629	CbGbCtD
Losartan—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0124	0.043	CbGbCtD
Losartan—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.012	0.0419	CbGbCtD
Losartan—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0118	0.0411	CbGbCtD
Losartan—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0105	0.0366	CbGbCtD
Losartan—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0103	0.0358	CbGbCtD
Losartan—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00972	0.0338	CbGbCtD
Losartan—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00617	0.0215	CbGbCtD
Losartan—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00582	0.0203	CbGbCtD
Losartan—ACE—pulmonary artery—chronic obstructive pulmonary disease	0.00302	0.231	CbGeAlD
Losartan—SLC2A9—respiratory system—chronic obstructive pulmonary disease	0.0018	0.137	CbGeAlD
Losartan—SLC2A9—connective tissue—chronic obstructive pulmonary disease	0.00158	0.121	CbGeAlD
Losartan—SLC2A9—lung—chronic obstructive pulmonary disease	0.000953	0.0729	CbGeAlD
Losartan—AGTR1—connective tissue—chronic obstructive pulmonary disease	0.000606	0.0463	CbGeAlD
Losartan—SLCO1B3—lung—chronic obstructive pulmonary disease	0.000602	0.0461	CbGeAlD
Losartan—AGTR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000554	0.0424	CbGeAlD
Losartan—AGTR1—trachea—chronic obstructive pulmonary disease	0.000509	0.0389	CbGeAlD
Losartan—ACE—respiratory system—chronic obstructive pulmonary disease	0.000508	0.0389	CbGeAlD
Losartan—Irbesartan—CYP1A2—chronic obstructive pulmonary disease	0.000478	0.567	CrCbGaD
Losartan—ACE—connective tissue—chronic obstructive pulmonary disease	0.000447	0.0342	CbGeAlD
Losartan—ACE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000409	0.0313	CbGeAlD
Losartan—AGTR1—lung—chronic obstructive pulmonary disease	0.000365	0.0279	CbGeAlD
Losartan—Valsartan—ALB—chronic obstructive pulmonary disease	0.000364	0.432	CrCbGaD
Losartan—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000349	0.0267	CbGeAlD
Losartan—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000337	0.0258	CbGeAlD
Losartan—ACE—lung—chronic obstructive pulmonary disease	0.00027	0.0206	CbGeAlD
Losartan—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000194	0.00146	CcSEcCtD
Losartan—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00146	CcSEcCtD
Losartan—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00145	CcSEcCtD
Losartan—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00145	CcSEcCtD
Losartan—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00144	CcSEcCtD
Losartan—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00144	CcSEcCtD
Losartan—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00144	CcSEcCtD
Losartan—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00144	CcSEcCtD
Losartan—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00144	CcSEcCtD
Losartan—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00143	CcSEcCtD
Losartan—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00143	CcSEcCtD
Losartan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000189	0.00143	CcSEcCtD
Losartan—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.00142	CcSEcCtD
Losartan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00142	CcSEcCtD
Losartan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00141	CcSEcCtD
Losartan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00141	CcSEcCtD
Losartan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00141	CcSEcCtD
Losartan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00141	CcSEcCtD
Losartan—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000186	0.0014	CcSEcCtD
Losartan—Infection—Formoterol—chronic obstructive pulmonary disease	0.000186	0.0014	CcSEcCtD
Losartan—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.0014	CcSEcCtD
Losartan—CYP1A2—lung—chronic obstructive pulmonary disease	0.000185	0.0142	CbGeAlD
Losartan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00139	CcSEcCtD
Losartan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00139	CcSEcCtD
Losartan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00139	CcSEcCtD
Losartan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000184	0.00139	CcSEcCtD
Losartan—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00138	CcSEcCtD
Losartan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00138	CcSEcCtD
Losartan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00138	CcSEcCtD
Losartan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00138	CcSEcCtD
Losartan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.00138	CcSEcCtD
Losartan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00138	CcSEcCtD
Losartan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00138	CcSEcCtD
Losartan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00137	CcSEcCtD
Losartan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00137	CcSEcCtD
Losartan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00137	CcSEcCtD
Losartan—Infection—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00137	CcSEcCtD
Losartan—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00137	CcSEcCtD
Losartan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000181	0.00136	CcSEcCtD
Losartan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00136	CcSEcCtD
Losartan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00135	CcSEcCtD
Losartan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00135	CcSEcCtD
Losartan—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000179	0.0137	CbGeAlD
Losartan—CYP3A5—lung—chronic obstructive pulmonary disease	0.000179	0.0137	CbGeAlD
Losartan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00133	CcSEcCtD
Losartan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00133	CcSEcCtD
Losartan—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00132	CcSEcCtD
Losartan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00131	CcSEcCtD
Losartan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00131	CcSEcCtD
Losartan—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00131	CcSEcCtD
Losartan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.00131	CcSEcCtD
Losartan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00131	CcSEcCtD
Losartan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.0013	CcSEcCtD
Losartan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.0013	CcSEcCtD
Losartan—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000172	0.0013	CcSEcCtD
Losartan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.00128	CcSEcCtD
Losartan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00128	CcSEcCtD
Losartan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00128	CcSEcCtD
Losartan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00128	CcSEcCtD
Losartan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00127	CcSEcCtD
Losartan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00127	CcSEcCtD
Losartan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00127	CcSEcCtD
Losartan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00127	CcSEcCtD
Losartan—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00126	CcSEcCtD
Losartan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00126	CcSEcCtD
Losartan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00125	CcSEcCtD
Losartan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00125	CcSEcCtD
Losartan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00125	CcSEcCtD
Losartan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00125	CcSEcCtD
Losartan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00125	CcSEcCtD
Losartan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00124	CcSEcCtD
Losartan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00124	CcSEcCtD
Losartan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00124	CcSEcCtD
Losartan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00124	CcSEcCtD
Losartan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00123	CcSEcCtD
Losartan—Injury—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00123	CcSEcCtD
Losartan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00123	CcSEcCtD
Losartan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00122	CcSEcCtD
Losartan—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00122	CcSEcCtD
Losartan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00121	CcSEcCtD
Losartan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00121	CcSEcCtD
Losartan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00121	CcSEcCtD
Losartan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00121	CcSEcCtD
Losartan—Pain—Formoterol—chronic obstructive pulmonary disease	0.00016	0.0012	CcSEcCtD
Losartan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.0012	CcSEcCtD
Losartan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00016	0.0012	CcSEcCtD
Losartan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.0012	CcSEcCtD
Losartan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.0012	CcSEcCtD
Losartan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00119	CcSEcCtD
Losartan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00119	CcSEcCtD
Losartan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00118	CcSEcCtD
Losartan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00118	CcSEcCtD
Losartan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00118	CcSEcCtD
Losartan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00118	CcSEcCtD
Losartan—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00117	CcSEcCtD
Losartan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00117	CcSEcCtD
Losartan—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00117	CcSEcCtD
Losartan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00117	CcSEcCtD
Losartan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00116	CcSEcCtD
Losartan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00116	CcSEcCtD
Losartan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00116	CcSEcCtD
Losartan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00116	CcSEcCtD
Losartan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000154	0.00116	CcSEcCtD
Losartan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00116	CcSEcCtD
Losartan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00115	CcSEcCtD
Losartan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00115	CcSEcCtD
Losartan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00115	CcSEcCtD
Losartan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00115	CcSEcCtD
Losartan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00114	CcSEcCtD
Losartan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00114	CcSEcCtD
Losartan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00113	CcSEcCtD
Losartan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00112	CcSEcCtD
Losartan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00112	CcSEcCtD
Losartan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00111	CcSEcCtD
Losartan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00111	CcSEcCtD
Losartan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00111	CcSEcCtD
Losartan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00111	CcSEcCtD
Losartan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00111	CcSEcCtD
Losartan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.0011	CcSEcCtD
Losartan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.0011	CcSEcCtD
Losartan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.0011	CcSEcCtD
Losartan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00109	CcSEcCtD
Losartan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00109	CcSEcCtD
Losartan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.00109	CcSEcCtD
Losartan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00109	CcSEcCtD
Losartan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00109	CcSEcCtD
Losartan—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00109	CcSEcCtD
Losartan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00109	CcSEcCtD
Losartan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00106	CcSEcCtD
Losartan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00105	CcSEcCtD
Losartan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00105	CcSEcCtD
Losartan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00104	CcSEcCtD
Losartan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00104	CcSEcCtD
Losartan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.00104	CcSEcCtD
Losartan—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00103	CcSEcCtD
Losartan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00102	CcSEcCtD
Losartan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00101	CcSEcCtD
Losartan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00101	CcSEcCtD
Losartan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.000996	CcSEcCtD
Losartan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000132	0.000996	CcSEcCtD
Losartan—ABCB1—trachea—chronic obstructive pulmonary disease	0.000132	0.0101	CbGeAlD
Losartan—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000994	CcSEcCtD
Losartan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000989	CcSEcCtD
Losartan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000979	CcSEcCtD
Losartan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000975	CcSEcCtD
Losartan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000963	CcSEcCtD
Losartan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000963	CcSEcCtD
Losartan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000958	CcSEcCtD
Losartan—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000955	CcSEcCtD
Losartan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000953	CcSEcCtD
Losartan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000943	CcSEcCtD
Losartan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00094	CcSEcCtD
Losartan—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000934	CcSEcCtD
Losartan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000931	CcSEcCtD
Losartan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000931	CcSEcCtD
Losartan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000911	CcSEcCtD
Losartan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000909	CcSEcCtD
Losartan—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000897	CcSEcCtD
Losartan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000895	CcSEcCtD
Losartan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000895	CcSEcCtD
Losartan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000887	CcSEcCtD
Losartan—Rash—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000887	CcSEcCtD
Losartan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000886	CcSEcCtD
Losartan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000886	CcSEcCtD
Losartan—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000886	CcSEcCtD
Losartan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000882	CcSEcCtD
Losartan—Headache—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000882	CcSEcCtD
Losartan—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00088	CcSEcCtD
Losartan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000879	CcSEcCtD
Losartan—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000878	CcSEcCtD
Losartan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000876	CcSEcCtD
Losartan—Rash—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000869	CcSEcCtD
Losartan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000868	CcSEcCtD
Losartan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000866	CcSEcCtD
Losartan—Headache—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000863	CcSEcCtD
Losartan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000853	CcSEcCtD
Losartan—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000851	CcSEcCtD
Losartan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000845	CcSEcCtD
Losartan—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000842	CcSEcCtD
Losartan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000839	CcSEcCtD
Losartan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000838	CcSEcCtD
Losartan—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000837	CcSEcCtD
Losartan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000837	CcSEcCtD
Losartan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000836	CcSEcCtD
Losartan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000836	CcSEcCtD
Losartan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000832	CcSEcCtD
Losartan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000821	CcSEcCtD
Losartan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000819	CcSEcCtD
Losartan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000789	CcSEcCtD
Losartan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000785	CcSEcCtD
Losartan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000762	CcSEcCtD
Losartan—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000762	CcSEcCtD
Losartan—Shock—Prednisolone—chronic obstructive pulmonary disease	9.96e-05	0.00075	CcSEcCtD
Losartan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000744	CcSEcCtD
Losartan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.78e-05	0.000737	CcSEcCtD
Losartan—Flushing—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000723	CcSEcCtD
Losartan—ABCB1—lung—chronic obstructive pulmonary disease	9.5e-05	0.00726	CbGeAlD
Losartan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000707	CcSEcCtD
Losartan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.25e-05	0.000696	CcSEcCtD
Losartan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.15e-05	0.000689	CcSEcCtD
Losartan—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000689	CcSEcCtD
Losartan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.09e-05	0.000684	CcSEcCtD
Losartan—Erythema—Prednisone—chronic obstructive pulmonary disease	9.01e-05	0.000679	CcSEcCtD
Losartan—Pain—Prednisolone—chronic obstructive pulmonary disease	8.65e-05	0.000652	CcSEcCtD
Losartan—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000639	CcSEcCtD
Losartan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.36e-05	0.00063	CcSEcCtD
Losartan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.34e-05	0.000628	CcSEcCtD
Losartan—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000627	CcSEcCtD
Losartan—Agitation—Prednisone—chronic obstructive pulmonary disease	8.28e-05	0.000624	CcSEcCtD
Losartan—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.00062	CcSEcCtD
Losartan—Malaise—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000612	CcSEcCtD
Losartan—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.1e-05	0.00061	CcSEcCtD
Losartan—Syncope—Prednisone—chronic obstructive pulmonary disease	8.08e-05	0.000608	CcSEcCtD
Losartan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.04e-05	0.000605	CcSEcCtD
Losartan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000596	CcSEcCtD
Losartan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000578	CcSEcCtD
Losartan—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000578	CcSEcCtD
Losartan—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.64e-05	0.000576	CcSEcCtD
Losartan—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000571	CcSEcCtD
Losartan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.46e-05	0.000561	CcSEcCtD
Losartan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000554	CcSEcCtD
Losartan—Oedema—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000554	CcSEcCtD
Losartan—Infection—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.00055	CcSEcCtD
Losartan—Shock—Prednisone—chronic obstructive pulmonary disease	7.23e-05	0.000545	CcSEcCtD
Losartan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.21e-05	0.000543	CcSEcCtD
Losartan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.00054	CcSEcCtD
Losartan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.11e-05	0.000535	CcSEcCtD
Losartan—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000528	CcSEcCtD
Losartan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000505	CcSEcCtD
Losartan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.69e-05	0.000504	CcSEcCtD
Losartan—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000501	CcSEcCtD
Losartan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000497	CcSEcCtD
Losartan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000487	CcSEcCtD
Losartan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.39e-05	0.000481	CcSEcCtD
Losartan—Rash—Prednisolone—chronic obstructive pulmonary disease	6.38e-05	0.000481	CcSEcCtD
Losartan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.37e-05	0.00048	CcSEcCtD
Losartan—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000477	CcSEcCtD
Losartan—Headache—Prednisolone—chronic obstructive pulmonary disease	6.34e-05	0.000477	CcSEcCtD
Losartan—Constipation—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000474	CcSEcCtD
Losartan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.000456	CcSEcCtD
Losartan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.000453	CcSEcCtD
Losartan—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.01e-05	0.000453	CcSEcCtD
Losartan—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.00044	CcSEcCtD
Losartan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000438	CcSEcCtD
Losartan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000438	CcSEcCtD
Losartan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.42e-05	0.000408	CcSEcCtD
Losartan—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000397	CcSEcCtD
Losartan—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000392	CcSEcCtD
Losartan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000379	CcSEcCtD
Losartan—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000366	CcSEcCtD
Losartan—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000352	CcSEcCtD
Losartan—Rash—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000349	CcSEcCtD
Losartan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000349	CcSEcCtD
Losartan—Headache—Prednisone—chronic obstructive pulmonary disease	4.61e-05	0.000347	CcSEcCtD
Losartan—Nausea—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000329	CcSEcCtD
Losartan—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	2.53e-05	0.000308	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.52e-05	0.000308	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.49e-05	0.000304	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.46e-05	0.000301	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.46e-05	0.0003	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.43e-05	0.000297	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	2.42e-05	0.000296	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	2.41e-05	0.000294	CbGpPWpGaD
Losartan—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.4e-05	0.000294	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.37e-05	0.000289	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.37e-05	0.000289	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.35e-05	0.000287	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.35e-05	0.000287	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.33e-05	0.000285	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.32e-05	0.000284	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000283	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.3e-05	0.000281	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.3e-05	0.000281	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.25e-05	0.000275	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.24e-05	0.000274	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.23e-05	0.000273	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.000272	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000271	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000268	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.18e-05	0.000267	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.16e-05	0.000264	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.15e-05	0.000262	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.14e-05	0.000261	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.12e-05	0.000259	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.12e-05	0.000259	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.1e-05	0.000256	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.09e-05	0.000256	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.09e-05	0.000255	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.08e-05	0.000255	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.07e-05	0.000253	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.06e-05	0.000251	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.97e-05	0.000241	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.97e-05	0.000241	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.95e-05	0.000238	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.95e-05	0.000238	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.92e-05	0.000234	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.000234	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.89e-05	0.000231	CbGpPWpGaD
Losartan—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.87e-05	0.000228	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.000224	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000223	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.81e-05	0.000221	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.79e-05	0.000219	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.79e-05	0.000218	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.78e-05	0.000218	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.77e-05	0.000217	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.76e-05	0.000215	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.76e-05	0.000215	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.76e-05	0.000215	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.73e-05	0.000211	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.00021	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.00021	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.71e-05	0.000208	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.7e-05	0.000208	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000208	CbGpPWpGaD
Losartan—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.7e-05	0.000207	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.000207	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000207	CbGpPWpGaD
Losartan—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.69e-05	0.000206	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000206	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.66e-05	0.000203	CbGpPWpGaD
Losartan—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.65e-05	0.000202	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.0002	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.63e-05	0.000199	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.62e-05	0.000198	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.61e-05	0.000196	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.59e-05	0.000194	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.58e-05	0.000193	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.56e-05	0.000191	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.00019	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.54e-05	0.000189	CbGpPWpGaD
Losartan—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.53e-05	0.000187	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.52e-05	0.000186	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.52e-05	0.000186	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.51e-05	0.000185	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.5e-05	0.000184	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.5e-05	0.000183	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.000183	CbGpPWpGaD
Losartan—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.000182	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.48e-05	0.000181	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.47e-05	0.000179	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000179	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.45e-05	0.000178	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.45e-05	0.000177	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.45e-05	0.000177	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.000177	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000175	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.42e-05	0.000174	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	0.000173	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.39e-05	0.00017	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000169	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.38e-05	0.000169	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.38e-05	0.000168	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000168	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.35e-05	0.000165	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.35e-05	0.000165	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.34e-05	0.000164	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.33e-05	0.000162	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.32e-05	0.000161	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.32e-05	0.000161	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	0.00016	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000156	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000156	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.000155	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.26e-05	0.000153	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.00015	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000149	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.22e-05	0.000149	CbGpPWpGaD
Losartan—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.2e-05	0.000147	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.000147	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000146	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.19e-05	0.000145	CbGpPWpGaD
Losartan—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.18e-05	0.000144	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.18e-05	0.000144	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000144	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.15e-05	0.000141	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000141	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.12e-05	0.000137	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.1e-05	0.000135	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000134	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000134	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.000134	CbGpPWpGaD
Losartan—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.09e-05	0.000133	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.08e-05	0.000132	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.08e-05	0.000132	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.07e-05	0.000131	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000128	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000127	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-05	0.000126	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.03e-05	0.000126	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000125	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.01e-05	0.000123	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000122	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	9.79e-06	0.00012	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.7e-06	0.000118	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	9.64e-06	0.000118	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.53e-06	0.000116	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	9.44e-06	0.000115	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.26e-06	0.000113	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	9.22e-06	0.000113	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.16e-06	0.000112	CbGpPWpGaD
Losartan—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.14e-06	0.000112	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.08e-06	0.000111	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.07e-06	0.000111	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.02e-06	0.00011	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.96e-06	0.00011	CbGpPWpGaD
Losartan—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	8.91e-06	0.000109	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.91e-06	0.000109	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.84e-06	0.000108	CbGpPWpGaD
Losartan—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.73e-06	0.000107	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.7e-06	0.000106	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	8.7e-06	0.000106	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.55e-06	0.000104	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.36e-06	0.000102	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	8.32e-06	0.000102	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.28e-06	0.000101	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.18e-06	9.99e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	8.13e-06	9.94e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.09e-06	9.89e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	8e-06	9.77e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.9e-06	9.65e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.84e-06	9.58e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.81e-06	9.54e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.54e-06	9.21e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.49e-06	9.15e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.46e-06	9.11e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.45e-06	9.11e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.38e-06	9.02e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.3e-06	8.92e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.29e-06	8.91e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.26e-06	8.87e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.16e-06	8.74e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.13e-06	8.71e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.09e-06	8.66e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.07e-06	8.64e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.92e-06	8.46e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.8e-06	8.31e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.76e-06	8.26e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.73e-06	8.22e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.67e-06	8.15e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.66e-06	8.13e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.57e-06	8.02e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	6.48e-06	7.91e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.37e-06	7.78e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.32e-06	7.72e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.31e-06	7.7e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.29e-06	7.68e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.29e-06	7.68e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.25e-06	7.63e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.23e-06	7.62e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.2e-06	7.57e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.2e-06	7.57e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.16e-06	7.53e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.13e-06	7.49e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.84e-06	7.14e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.81e-06	7.1e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.78e-06	7.06e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.77e-06	7.05e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.74e-06	7.02e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.73e-06	7e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.69e-06	6.95e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.61e-06	6.85e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.53e-06	6.76e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.48e-06	6.69e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.48e-06	6.69e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.44e-06	6.65e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.4e-06	6.6e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.16e-06	6.3e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.12e-06	6.25e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.04e-06	6.16e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.03e-06	6.15e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.89e-06	5.97e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.87e-06	5.95e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.81e-06	5.88e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.81e-06	5.88e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.77e-06	5.83e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	4.75e-06	5.81e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.7e-06	5.74e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.46e-06	5.44e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.4e-06	5.38e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.39e-06	5.36e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.37e-06	5.34e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.31e-06	5.27e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.3e-06	5.25e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.11e-06	5.02e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.04e-06	4.94e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.02e-06	4.91e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.81e-06	4.65e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.72e-06	4.55e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.56e-06	4.35e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	3.54e-06	4.32e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.37e-06	4.12e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.33e-06	4.06e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.32e-06	4.06e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.24e-06	3.96e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.18e-06	3.88e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.1e-06	3.79e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.1e-06	3.79e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-06	3.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.94e-06	3.59e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	3.54e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.59e-06	3.16e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.48e-06	3.02e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2e-06	2.44e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-06	2.33e-05	CbGpPWpGaD
